Stocks to Buy

Whether you are a novice who just opened your first 401k or you are a seasoned investor, you have to spend countless hours researching stocks to buy. Who has that kind of time? We do. Powered by a diverse group of perspectives formed from dozens of analysts, advisors and strategists, our stories digest the day’s biggest headlines to uncover which stocks you should buy.

Applied Materials, Inc. (AMAT) Stock Is Still a Winner in 2017 and Beyond

By Brian Wu, InvestorPlace Contributor
Applied Materials is sitting on a strong cyclical upturn in equipment spending, which makes AMAT stock a fantastic choice.

Here’s Why Bank of America Corp (BAC) Stock Will Gain 25%

By Richard Saintvilus, InvestorPlace Contributor
Given BofA's working strategy of cutting costs while growing revenue, the bank’s profitability should push BAC stock higher.

Why Alphabet Inc (GOOG) Stock Is Unstoppable Despite Any Pitfalls

By Josh Enomoto, InvestorPlace Contributor
Although investors might not be impressed by Alphabet Inc (GOOG) stock, the company is still the king of the internet.

Why Morgan Stanley Stock (MS) Might be a Great Pick for Investors

By
Morgan Stanley (MS) is seeing solid earnings estimate revision activity, and is a great company from a Zacks Industry Rank perspective.

Alibaba Group Holding Ltd (BABA) Stock Will Hit All-Time Highs Soon

By Dana Blankenhorn, InvestorPlace Contributor
Alibaba's (BABA) record Q3 was bolstered by triple-digit growth in several areas. BABA stock holders are right to ignore the earnings miss.

How Intel Corporation Ranks As a Top Analyst Pick (INTC)

By
A study of recommendations at the major brokerages shows Intel as the #8 broker pick, on average, out of the Dow Jones Industrial Average

Exxon Mobil Corporation (XOM) Stock Catches Permian Fever

By Aaron Levitt, InvestorPlace Contributor
Exxon finally pulls out its wallet to make a buyout and it's a doozy. In the end, it'll be a big win XOM stock long term.

Intercept Pharmaceuticals Inc (ICPT) Stock Could Be Biotech’s Grand Slam

By Charles Payne
Markets have meandered this year, but don’t think there aren’t opportunities, especially in biotech. Consider Intercept Pharma (ICPT) stock.

10 Stocks to Buy to Survive a “Trumpsy-Turvy” 2017

By Vince Martin, InvestorPlace Contributor
Political and economic uncertainty seem likely to make 2017 a volatile year. Here are 10 stocks to buy that can manage that volatility.

10 Companies That Are Bringing Jobs Back to America

By Brad Moon, InvestorPlace Contributor
President Donald Trump started the trend with Carrier, and we’ve put together a list of 10 companies that are bringing jobs back to America.

Ford Motor Company (F) Stock Will Gain 20% in Trump’s First Year

By Richard Saintvilus, InvestorPlace Contributor
Ford Motor Company (F) stock is cheap and you'd do better by your portfolio if you owned Ford stock outright rather than trading it.

Abbot Laboratories (ABT) Stock Should Start to Sizzle in 2017

By Hilary Kramer, Editor, GameChangers
With Abbott Laboratories' smart additions and subtractions, we could be on the brink of a big turnaround for ABT stock.

Illinois Tool Works Inc. Q4 Earnings: What’s in Store For ITW Investors?

By
Illinois Tool Works is set to release fourth quarter and full year-2016 results on Jan 25. Here's what to expect from ITW...

3 Growth Stocks Under $10 To Buy Now (CRNT, AKS, MIXT)

By
Check out these 3 growth stocks trading for under $10 per share. All of these companies currently hold a Zacks Rank #1 (Strong Buy) rating

5 Funds That Could Double Your Retirement Nest Egg

By
If you want to save a million dollars, you need to save a ton of money over a lifetime. You can get started with these 5 funds...

3 Reasons Facebook Inc (FB) Stock Will Keep Delivering in 2017

By Marie Brodbeck, InvestorPlace Contributor
FB stock has the potential to keep rising this year as Facebook’s messaging services develop and create new revenue streams for the company.

Under Armour Inc (UA) vs. Nike Inc (NKE): These 3 Stats Tell it All

By Will Ashworth, InvestorPlace Contributor
Over the next four years, Macquarie estimates that annual sales will grow by at least 4%, possibly as high as 5.6%, delivering better growth than the previous decade. Equally important, it sees profit margins increasing through supply chain efficiencies and product innovation.

3M Co Q4 Earnings: What’s in the Cards for MMM Stock?

By
Let's see how things are shaping up for 3M (MMM) this earnings season and what it means for MMM stock

7 Straight-A Stocks to Build Your Portfolio Around

By Louis Navellier, Editor, Growth Investor
They don't get a lot of press, but if you're looking for outperformance, then these seven straight A stocks sure have it.
Load More Articles